SCORE2 to explore primary, secondary therapies for CRVO

WAILEA, Hawaii — A new study is designed to examine first- and second-line treatments for central retinal vein occlusion, a speaker told colleagues here.Michael S. Ip, MD, discussed design protocols for the Study of Comparative Treatments in Retinal Vein Occlusion 2 (SCORE2) at Retina 2015.